These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17588958)

  • 21. Dystrophin as a mechanochemical transducer in skeletal muscle.
    Brown SC; Lucy JA
    Bioessays; 1993 Jun; 15(6):413-9. PubMed ID: 8357344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Construction of recombinant plasmid pVAX1-microdystrophin and preliminary study on the treatment to Duchenne muscular dystrophy].
    Xiong F; Zhang C; Zheng H; Xiao S; Yu M; Xu Y; Liu Z; Zhou C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):624-8. PubMed ID: 19065517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regions downstream from the WW domain of dystrophin are important for binding to postsynaptic densities in the brain.
    Sakamoto T; Arima T; Ishizaki M; Kawano R; Koide T; Uchida Y; Yamashita S; Kimura E; Hirano T; Maeda Y; Uchino M
    Neuromuscul Disord; 2008 May; 18(5):382-8. PubMed ID: 18378139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of exon 16 of the dystrophin gene is not associated with disease.
    Schwartz M; Dunø M; Palle AL; Krag T; Vissing J
    Hum Mutat; 2007 Feb; 28(2):205. PubMed ID: 17226814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer.
    Wu B; Moulton HM; Iversen PL; Jiang J; Li J; Li J; Spurney CF; Sali A; Guerron AD; Nagaraju K; Doran T; Lu P; Xiao X; Lu QL
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):14814-9. PubMed ID: 18806224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo delivery of naked antisense oligos in aged mdx mice: analysis of dystrophin restoration in skeletal and cardiac muscle.
    Vitiello L; Bassi N; Campagnolo P; Zaccariotto E; Occhi G; Malerba A; Pigozzo S; Reggiani C; Ausoni S; Zaglia T; Gamba P; Baroni MD; Ditadi AP
    Neuromuscul Disord; 2008 Aug; 18(8):597-605. PubMed ID: 18602263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse models of two missense mutations in actin-binding domain 1 of dystrophin associated with Duchenne or Becker muscular dystrophy.
    McCourt JL; Talsness DM; Lindsay A; Arpke RW; Chatterton PD; Nelson DM; Chamberlain CM; Olthoff JT; Belanto JJ; McCourt PM; Kyba M; Lowe DA; Ervasti JM
    Hum Mol Genet; 2018 Feb; 27(3):451-462. PubMed ID: 29194514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The structure of the N-terminal actin-binding domain of human dystrophin and how mutations in this domain may cause Duchenne or Becker muscular dystrophy.
    Norwood FL; Sutherland-Smith AJ; Keep NH; Kendrick-Jones J
    Structure; 2000 May; 8(5):481-91. PubMed ID: 10801490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoplasmic gamma-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle.
    Hanft LM; Rybakova IN; Patel JR; Rafael-Fortney JA; Ervasti JM
    Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5385-90. PubMed ID: 16565216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preliminary study of the spatial structural and functional changes of dystrophin after exon-3 deletion].
    Liang YY; Zhang C; Chen SL; Feng SW
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):938-41. PubMed ID: 18583232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 2-bp deletion in exon 74 of the dystrophin gene does not clearly induce muscle weakness.
    Kimura S; Ito K; Ueno H; Ikezawa M; Takeshima Y; Yoshioka K; Ozasa S; Nakamura K; Nomura K; Matsukura M; Mitsui K; Matsuo M; Miike T
    Brain Dev; 2009 Feb; 31(2):169-72. PubMed ID: 18430534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-decorated dystrophin molecule of murine skeletal myofiber as seen by freeze-etching electron microscopy.
    Wakayama Y; Shibuya S
    J Electron Microsc (Tokyo); 1991 Apr; 40(2):143-5. PubMed ID: 1895031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.
    Wang B; Li J; Fu FH; Xiao X
    J Orthop Res; 2009 Apr; 27(4):421-6. PubMed ID: 18973234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamics of Dystrophin's Actin-Binding Domain.
    Fealey ME; Horn B; Coffman C; Miller R; Lin AY; Thompson AR; Schramel J; Groth E; Hinderliter A; Cembran A; Thomas DD
    Biophys J; 2018 Aug; 115(3):445-454. PubMed ID: 30007583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
    Banks GB; Chamberlain JS
    Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dystrophin binding to nonmuscle actin.
    Renley BA; Rybakova IN; Amann KJ; Ervasti JM
    Cell Motil Cytoskeleton; 1998; 41(3):264-70. PubMed ID: 9829780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathology.
    Ghahramani Seno MM; Graham IR; Athanasopoulos T; Trollet C; Pohlschmidt M; Crompton MR; Dickson G
    Hum Mol Genet; 2008 Sep; 17(17):2622-32. PubMed ID: 18511456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular diagnosis of Duchenne/Becker muscular dystrophy: enhanced detection of dystrophin gene rearrangements by oligonucleotide array-comparative genomic hybridization.
    del Gaudio D; Yang Y; Boggs BA; Schmitt ES; Lee JA; Sahoo T; Pham HT; Wiszniewska J; Chinault AC; Beaudet AL; Eng CM
    Hum Mutat; 2008 Sep; 29(9):1100-7. PubMed ID: 18752307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.
    Aartsma-Rus A; Janson AA; van Ommen GJ; van Deutekom JC
    BMC Med Genet; 2007 Jul; 8():43. PubMed ID: 17612397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing interaction of actin and actin-binding domain 1 of dystrophin with modulators: Toward improved gene therapy for Duchenne muscular dystrophy.
    Guhathakurta P; Carter AL; Thompson AR; Kurila D; LaFrence J; Zhang L; Trask JR; Vanderheyden B; Muretta JM; Ervasti JM; Thomas DD
    J Biol Chem; 2022 Dec; 298(12):102675. PubMed ID: 36372234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.